Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 13 November 2009, doi:10.1136/bmj.b4807
Cite this as: BMJ 2009;339:b4807
Clare Dyer
1 BMJ
| The first 150 words of the full text of this article appear below. |
The row between the UK government and its advisory council on the misuse of drugs has deepened, with the resignations of three further members, leaving it without some of the representatives required by statute for it to do its work.
Their resignations bring to five the total who have quit in protest at the sacking of the councils head, David Nutt. It is now short of the representatives from pharmacy, the pharmaceutical industry, and chemistry, which are required by the Misuse of Drugs Act, and is likely to face reluctance on the part of scientists to take up the unpaid posts.
Professor Nutt, a neuropsychopharmacologist from Imperial College, London, and Bristol University, was dismissed by the home secretary, Alan Johnson, last month after the publication of a lecture in which he said that cannabis was less harmful than tobacco and alcohol.
Two of the councils members, the chemist Les King
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?